From
to ZETA
High-Tech Plant for Antibody-Drug Conjugation
ZETA delivers an ADC downstream processing system in 18 months.
Skid-based design and precision engineering support safe, GMP-compliant production of antibody-drug conjugates in Switzerland.
Mastered challenges.
Customized solution
Controlled freezing, transport, storage and thawing of the sensitive substances effectively accomplished.
Efficient cooling
Development of a specific vessel geometry for ultrafiltration.
Vessel cleanability
Spray ball design and cleaning procedure ensured complete toxin removal.